数字口腔抗癌剂干预的可行性,可接受性和潜在影响:试点随机对照试验的协议
Saima Ahmed1,2, Christine Maheu3, Walter Gotlieb1,2,4,5
1Division of Experimental Medicine, Faculty of Medicine and Health Sciences, McGill University, Montreal, QC, Canada.
JMIR research protocols
|March 26, 2025
概括
这项研究探讨了口服抗癌药物 (OAA) 的数字干预,以改善坚持和减少症状困扰. 结果即将到来,但该干预措施对癌症患者的支持有希望.
科学领域:
- 在瘤学瘤学.
- 数字健康数字健康
- 患者支持 患者支持
背景情况:
- 服用口服抗癌药物 (OAAs) 的患者需要加强对坚持,监测和副作用管理的支持.
- 在OAA治疗中的挑战需要创新的信息和支持干预措施.
研究的目的:
- 评估OAAs患者数字干预的可行性,可接受性和潜在影响.
- 用自我效能理论来改善药物坚持和减少症状困扰.
主要方法:
- 一个双臂试点随机对照试验,涉及52名参与者.
- 干预包括信息视频,电子手册,护士电话和电子提醒.
- 混合方法方法采用电子问卷和半结构面试.
主要成果:
- 数据收集完成了41名参与者.
- 预计将在2025年公布全部结果.
结论:
- 该研究开发了一种基于理论的数字OAA干预方案,以适应患者需求.
- 混合方法方法提供了对干预影响的全面了解.
- 纵向跟踪捕捉了口服治疗过程和结果的变化.
相关概念视频
Clinical Trials
6.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.6K
Clinical Trials: Overview
2.6K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.6K
Cancer Survival Analysis
313
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
313

